Merit Medical Systems (FRA:MM3) Accounts Receivable: €195 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM3 Merit Medical Systems Inc FRA:MM3
83 GF Score
Price €77.50
GF Value €82.05
! 2 Warning Signs
View Full Analysis

What is Merit Medical Systems Accounts Receivable?

Merit Medical Systems FRA:MM3 -0.64% 83 Accounts Receivable is €195 Mil as of Jun. 2026. GuruFocus rates FRA:MM3 with a GF Score™ of 83/100 and a GF Value™ of €82.05. The stock has 2 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Merit Medical Systems's accounts receivables for the quarter that ended in Jun. 2026 was €195 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Merit Medical Systems's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 48.85.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Merit Medical Systems's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was €-5.52.

Merit Medical Systems Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Merit Medical Systems's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=194.638/363.556*91
=48.85

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Merit Medical Systems's accounts receivable are only considered to be worth 75% of book value:

Merit Medical Systems's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(389.471+0.75 * 194.638+0.5 * 324.729-1027.552
-0-0)/59.710
=-5.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Merit Medical Systems Accounts Receivable Related Terms

Merit Medical Systems Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems Accounts Receivable Chart

Merit Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 134.79 155.46 163.12 181.68 173.97

Merit Medical Systems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.01 179.17 173.97 178.58 194.64
FRA:MM3
83GF Score
Merit Medical Systems Inc FRA:MM3
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of €195 Mil mean?
Merit Medical Systems (FRA:MM3) has a Accounts Receivable of €195 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Merit Medical Systems and its competitors.
Is Merit Medical Systems' Accounts Receivable too high?
Merit Medical Systems' current Accounts Receivable is €195 Mil. Overall, Merit Medical Systems has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Accounts Receivable compare to NVST and MMED?
Merit Medical Systems' Accounts Receivable of €195 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Medical Devices & Instruments company?
A good Accounts Receivable depends on the Medical Devices & Instruments industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Merit Medical Systems and its competitors. Merit Medical Systems's current Accounts Receivable is €195 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Merit Medical Systems (FRA:MM3) has a current Accounts Receivable of €195 Mil. The stock's GF Value™ is €82.05, compared to a current price of €77.50 — trading 5.5% below its estimated fair value. The current Accounts Receivable is €195 Mil. Merit Medical Systems' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Accounts Receivable is €195 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of €77.50 is trading 5.5% below its estimated GF Value™ of €82.05.

Key valuation signals for FRA:MM3:

  • Accounts Receivable: €195 Mil
  • GF Value™: €82.05 vs. price of €77.50 (5.5% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merit Medical Systems Business Description

Other Exchanges MMSI:USA
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
83GF Score

Get the complete analysis for FRA:MM3

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€77.50
Price
€82.05
GF Value